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Background: We study the prevalence of acute myeloid leukemia (AML) among patients with severe gingival 
enlargement. 
Material and Methods: We retrospective reviewed the clinical records of patients with severe gingival enlargement, 
between 2011 and 2018. The Saxer and Mühlemann index were used to measure inflammation and gingival blee-
ding. The degree of dental mobility was measured by the Nyman and Lindhe technique.
Results: A correlation analysis was carried out to test whether there were any associations among the different 
variables. In the sample of 117 patients the mean gingival bleeding index was ≥3 and the degree of dental mobility 
≥2.3. 1.7% of patients, with severe gingival hyperplasia were diagnosed with AML. We found a significant associa-
tion between gingival bleeding and aging (p<0.001) and a trend (0.54) between bleeding and suffering from AML. 
Conclusions: Severe gingival enlargement, abundant gingival bleeding, and dental mobility could be early mani-
festations of a blood dyscrasia.




It essential for clinicians to have a sound knowledge of 
periodontal diseases, not only so that they are able to 
diagnose this type of pathologies, but also so that they 
may, in certain cases, learn their real origin when they 
appear as the first sign of a specific systemic disease.
The new classification scheme for periodontal diseases 
includes the subsection Hematological Conditions under 
the section Gingivitis mediated by systemic or local risk 
factors (1,2). 
The current classification associates aggressive perio-
dontitis (AP) with a low bacterial plaque burden but 
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with highly virulent bacteria such as porphyromonas 
gingivalis, actinobacillus actinomycetemcomitans or 
tannerella forsythia. The difference between the locali-
zed and the generalized forms only refers to the number 
of affected teeth (3). 
Leukemia is a hematological malignancy caused by the 
proliferation of the tissues that form white blood cells, 
leading to a sharp increase in circulating immature white 
blood cells.  
Acute myeloblastic leukemia (AML) is the most com-
mon type of acute leukemia in adults. The bone marrow 
is naturally responsible for producing a certain type of 
cells known as myeloblasts, which mature into granu-
locytes. In AML, myeloblasts proliferate abnormally, 
progressively invading the bone marrow and interfering 
with the production of normal blood cells.  
The incidence estimate is 2-3 cases/100,000 per year, 
gradually increasing with age to a peak of 12.6/100000 
in patients aged over 65 years old (4).
In addition to oral ulceration and infection and gingival 
bleeding, oral and periodontal manifestations of leuke-
mia consist of infiltration of gingivae by leukemic cells, 
resulting in gingival overgrowth, which develops into 
pseudo-pockets where dental biofilm accumulates pro-
ducing, in turn, a second inflammatory lesion that contri-
butes to gum enlargement, so that, gingival enlargement 
is as much the result of leukemic infiltration as of reacti-
ve gingival hyperplasia.  
Identifying gingival overgrowth as an initial oral mani-
festation of leukemic infiltration is extremely important 
for establishing an early diagnosis of acute leukemia (5). 
Therefore, with this study our aim is to review the preva-
lence of acute myeloid leukemia (AML) among patients 
with severe gingival enlargement treated in a dental cli-
nic.
Material and Methods
A retrospective review was carried out at the Dental Cli-
nic of the University of Salamanca between 2011 and 
2018 (both years included) based on a sample of 16,364 
patients, 117 of whom showed a picture of severe gin-
gival hyperplasia associated with spontaneous bleeding 
and tooth mobility. Of these 117, 62.3% were women 
and the average age was 59,18.
All the patients underwent periodontal exploration ac-
cording to a specific protocol, SEPA Code 4  (Spanish 
Society of Periodontology and Osseointegration), which 
consisted of a thorough periodontal study (periodontal 
chart, plaque index, gum bleeding, dental mobility, or-
thopantomography and an intraoral series of X-rays). In 
particular those that showed a bag probing greater than 
6 mm in 1 or more teeth of a sextant were considered as 
patients with severe gingival hyperplasia. Inflammation 
and gingival bleeding indices were measured using 
Saxer and Mühlemann’s Papillary Bleeding Index (PBI), 
which has proved very useful in public health programs 
(6). Tooth mobility was measured through the individual 
mechanical method, consisting of using two fingers to 
apply pressure on the crown of the tooth, followed by 
pressure in the buccolingual direction, registering the 
degree of tooth mobility according to the technique re-
commended by Nyman and Lindhe (7).
Patients were later referred to their corresponding pri-
mary healthcare centers to be finally examined and 
assessed by the Hematology Service of the Clinical 
University Hospital before establishing appropriate pe-
riodontal treatment. 
Pearson correlation using SPSS© 21.0.0.0 with a statis-
tical significance threshold of p<0.05 was used to check 
correlations among tooth mobility, gum bleeding index, 
age and suffering from ALM.  
Informed consent, formalized at the Dental Clinic, was 
obtained from all the patients participating in the study 
and was approved by the Bioethics Committee of the 
University of Salamanca in accordance with the Helsin-
ki Declaration of 1964.
Results
The study, based on a large initial sample of 16,364 pa-
tients, identified severe gingival hyperplasia in 0.71% 
(n=117), of whom 1.7% (n=2) were diagnosed with 
AML. The exploratory data reflected tooth mobility ave-
rages of ≥2.4 in women and ≥2.3 in men. The average 
bleeding index was ≥2.9 in women and ≥3.2 in men. The 
highest bleeding percentage was observed in women 
aged ≥62 and in men aged ≥63. Tables 1 and 2 show 
frequencies base on the determination of the gingival 
bleeding index and tooth mobility. 
Grade Frequency Percentage Cumulative
Percentage
1 1 0.9 0.9
2 19 16.2 17.1
3 66 56.4 73.5
4 31 26.5 100.0
Total 117 100.0 100.0
Table 1: Bleeding index according to Saxer-Mühlemann Index*.
*All patients with severe gingival hyperplasia were evaluated for gingival tooth bleed-
ing (n=117).
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Analyzing the data looking for the prevalence among 
these patients, the correlation test revealed a highly 
significant correlation between gingival bleeding in-
dex and age, with a Pearson correlation coefficient of 
0.361 (p<0.001). No significant association was found 
between age and tooth mobility (Pearson correlation co-
efficient 0.001, p=0.995).
In this study, 1.7 % (n=2) of the patients subjected to 
the specific protocol established (SEPA Code 4), spe-
cifically, a woman and a man with a mean age of 66, 
were diagnosed with AML. Both patients scored 3 on the 
bleeding index and were assessed with degree 4 tooth 
mobility, which are the highest Saxer-Mühlemann and 
Nyman-Lindhe indexes, respectively.   
A correlation test was run to demonstrate the association 
between the presence or absence of AML and gingival 
bleeding and tooth mobility degrees. The Pearson co-
rrelation coefficient yielded by the analysis was 0.179, 
with an associated probability of 0.054, which, we be-
lieve, shows a trend towards association between high 
gingival bleeding index scores and suffering from AML. 
The same test was used to check whether there was any 
association between suffering from AML and dental 
mobility, obtaining a statistical figure of 0.131 with an 
associated p-value of 0.160.
Discussion
To our knowledge, the scientific literature produced 
to date includes no extensive studies linking gingival 
hyperplasia to AML, since most of those available refer 
only to the description of isolated clinical cases. Only 
Busjan et al (5), in a cross-sectional study, compared 
the oral mucosa lesions of 39 patients suffering from 
leukemia with those of 38 healthy patients, observing 
that 68% of the leukemia patients presented oral mucosa 
lesions, gingival hyperplasia being this study the most 
important finding.
Gürkan et al., (8) classify gingival tissue enlargement as 
hereditary, secondary to prolonged drug therapy (anticon-
vulsants, antihypertensive drugs, calcium channel-bloc-
king drugs and immunosuppressive drugs) and resulting 
from different pathological reactions, including under the 
latter a series of causes that contribute to gingival over-
growth, leukemic cell infiltration among them.   
Grade Frequency Percentage Cumulative
Percentage
1 8 6.8 6.8
2 55 47.0 53.8
3 54 46.2 100.0
Total 117 100.0 100.0
Table 2: Tooth Mobility according to Nyman-Lindhe index*.
*All patients with severe gingival hyperplasia were evaluated for tooth mobility.
However, we believe that the significance of our fin-
dings (Pearson correlation coefficient 0.361, p<0.001) 
could be diminished by the fact that periodontitis is the 
most common chronic inflammatory condition suffered 
by people over the age of 65 (60%) and that it usually 
appears in the form of gum bleeding (9).
Hence, this study highlights that, while there is no sig-
nificant correlation between gingival bleeding index 
and suffering from AML, there could be a certain trend 
between increased bleeding and AML. We believe that 
even without a significant correlation from a statistical 
point of view but with a trend (0.054), there is a clinical 
one that need to be reported, as far as we know, for the 
first time. Nevertheless, we are aware that, to substantia-
te this association, it would be necessary to increase the 
number of cases studied, which would probably require 
the design of a prospective study.
Conclusions
Protocolized assessment of gingival hyperplasia by 
dentists and clinicians, alongside a close collaboration 
between them and an increase in the number of multi-
centric collaborative studies could lead, under certain 
circumstances, to an early diagnosis of AML. 
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